Patent Assignment
Reel/Frame 051579/0845
Ucc Financing Statement
Recorded: 2020-01-13
Pages: 5
Assignor
URIGEN PHAMACEUTICALS, INC.
Executed: 2020-01-13
Assignee
PLATINUM MONTAUR LIFE SCIENCES, LLC AND AS AGENT
PO BOX 897, WINDWARD I, REGATTA OFFICE PARK, KY1-1103, C/O R&H RESTRUCTURING (CAYMAN) LTD., GRAND CAYMAN, CAYMAN ISLANDS
Covered Properties
(7)
Best-Deal List Generation
PCT:
PCT/US2012/023057 ↗
Stable Compositions Comprising Heparinoid, Acute-Acting Anesthetic, and Buffer
PCT:
PCT/US2014/013352 ↗
Compositions and Methods for Treatment of Diseases and Conditions Employing Oral Administration of Sodium Pentosan Polysulfate and Other Pentosan Polysulfate Salts
PCT:
PCT/US2015/017205 ↗
Novel Interstitial Therapy for Immediate Symptom Relief and Chronic Therapy in Interstitial Cystitis
Novel Interstitial Therapy for Immediate Symptom Relief and Chronic Therapy in Interstitial Cystitis
Kits and Improved Compositions for Treating Lower Urinary Tract Disorders
Application:
13/442,101 →
Publication:
US 2012/0196830
Novel Interstitial Therapy for Immediate Symptom Relief and Chronic Therapy in Interstitial Cystitis
Application:
15/274,972 →
Publication:
US 2017/0007638
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 27, 2005
From: PARSONS, C. LOWELL
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 016236/0776 →
Assignment of Assignor's Interest
Jul 1, 2005
From: PARSONS, C. LOWELL
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 016737/0046 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 35923/0749
Jul 19, 2017
From: IMMY FUNDING LLC
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 043259/0434 →
Assignment of Assignor's Interest
Oct 22, 2024
From: PARSONS, C. LOWELL
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 068973/0785 →
Change of Name
Oct 22, 2024
From: URIGEN PHARMACEUTICALS, INC.
To: VANELTIX PHARMA, INC.
Reel/Frame 068973/0895 →